Triple test proposed for prostate cancer screening

Above normal PSA levels and a negative biopsy result does not effectively confirm or deny the presence of prostate cancer, but a new test for a protein that stains positive for prostate cancer has shown promising results. EPCA is the protein that scientists have discovered has a positive correlation to the presence of cancer of the prostate and can be tested for, providing relatively sensitive detection to date. It can detect cancer in prostates that appear histologically normal, but later are shown to have developed cancer cells. It is being promoted in conjunction with biopsy of the prostate.

Source: summary of medical news story as reported by Pak Tribune.com

Related Disease Topics:

• Prostate cancer
• Cancer of the prostate

Article Source Details

About: Triple test proposed for prostate cancer screening

Date: 7 October 2005

Source: Pak Tribune.com

URL: http://www.paktribune.com/news/index.php?id=121601

Related Medical Topics

This summary article refers to the following medical categories:

• Surgery
• Surgery and prostate biopsy
• Surgery and biopsy of the prostate
• Risk and prostate cancer
• Risk and PSA
• Risk and prostate specific antigen
• Risk and prostate biopsy
• Risk and prostate screening
• Diagnosis
• Diagnosis and PSA
• Diagnosis and prostate specific antigen
• Diagnosis and prostate biopsy
• Diagnosis and biopsy of the prostate
• Diagnosis and prostate cancer
• Diagnosis and cancer of the prostate
• Diagnosis and prostate protein
• Diagnosis and tumor marker
• Research
• Research and prostate screening
• Research and prostate cancer
• Research and cancer of the prostate
• Research and PSA
• Research and prostate biopsy
• Research and biopsy of the prostate
• Research and prostate tissue sample
• Research and tumor marker
• Research and men's health

More News Topics

Search Specialists by State and City